SkinHealth Systems Inc. (SKIN)

SkinHealth Systems Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	204.07	230.67	368.06	523.03	568.2	901.89
Cash & Short-Term Investments	204.07	230.67	368.06	523.03	568.2	901.89
Cash Growth	-2.82%	-37.33%	-29.63%	-7.95%	-37.00%	9407.55%
Accounts Receivable	17.64	21.74	27.64	54.7	76.49	46.82
Other Receivables	1.99	1.7	0.82	15.33	7.28	4.6
Receivables	19.63	23.44	28.46	70.03	83.77	51.42
Inventory	46.84	48.01	69.11	91.32	109.66	35.26
Prepaid Expenses	22.69	5.4	9.49	13.88	21.65	12.32
Restricted Cash	2	2	2	-	-	-
Total Current Assets	295.24	309.52	477.12	698.25	783.28	1,001
Property, Plant & Equipment	21.49	14.11	19.57	26.35	33.82	31.18
Goodwill	126.35	126.62	123.5	125.82	124.59	123.69
Other Intangible Assets	30.22	35.76	47.51	62.12	46.39	56.01
Long-Term Deferred Tax Assets	2.35	1.93	3.89	0.53	0.82	0.33
Other Long-Term Assets	10.93	11.87	14.09	16.04	14.19	6.71
Total Assets	486.57	499.8	685.68	929.11	1,003	1,219

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	16.05	15.63	21.94	44.77	28.47	29.05
Accrued Expenses	43.55	39.32	35.26	41.42	35.04	40.45
Short-Term Debt	-	-	-	-	1.82	2.15
Current Portion of Long-Term Debt	103.09	123.96	-	-	-	-
Current Portion of Leases	3.86	5.13	5.15	4.6	4.96	3.71
Current Income Taxes Payable	0.48	1.23	3.43	2.76	1.43	0.29
Current Unearned Revenue	1.17	1.01	2.38	0.45	-	-
Other Current Liabilities	-	-	-	21.01	-	0.78
Total Current Liabilities	168.2	186.28	68.15	115.01	71.71	76.44
Long-Term Debt	242.12	240.43	552.2	738.37	734.14	729.91
Long-Term Leases	17.98	9.24	10.81	9.32	12.69	12.78
Long-Term Deferred Tax Liabilities	0.39	0.39	0.4	0.7	2.01	3.56
Other Long-Term Liabilities	2.32	2.41	2.32	6.32	15.47	93.82
Total Liabilities	431.01	438.75	633.88	869.72	836.03	916.51

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.01	0.01	0.01	0.01	0.01	0.02
Additional Paid-In Capital	583.74	579.96	566.71	541.28	550.32	722.25
Retained Earnings	-526.78	-517.48	-507.97	-478.87	-378.75	-418.71
Comprehensive Income & Other	-1.4	-1.43	-6.95	-3.04	-4.53	-1.26
Shareholders' Equity	55.57	61.06	51.8	59.39	167.05	302.3
Total Liabilities & Equity	486.57	499.8	685.68	929.11	1,003	1,219

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	367.04	378.76	568.16	752.29	753.61	748.56
Net Cash (Debt)	-162.97	-148.08	-200.1	-229.26	-185.41	153.33
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-1.27	-1.09	-1.40	-1.74	-1.25	1.50
Filing Date Shares Outstanding	130.14	127.77	125.25	123.43	132.5	150.6
Total Common Shares Outstanding	130.1	127.52	124.92	122.9	132.21	150.6
Working Capital	127.04	123.24	408.97	583.24	711.56	924.46
Book Value Per Share	0.43	0.48	0.41	0.48	1.26	2.01
Tangible Book Value	-101	-101.33	-119.21	-128.55	-3.93	122.59
Tangible Book Value Per Share	-0.78	-0.79	-0.95	-1.05	-0.03	0.81
Machinery	14.1	14.2	19.46	21.11	17.49	14.31
Construction In Progress	0.26	0.06	-	0.75	1.38	5.35
Leasehold Improvements	11.04	11.08	12.02	12.32	11.81	5.09

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: May 7, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 24, 2026

Data Sources Report a data error